Wang W, Liu X, Hou X, et al. - Individuals with cervical squamous cell carcinoma (SCC; n = 559) who were treated with definitive radiotherapy or concurrent chemoradiotherapy (CCRT) between June 2012 and May 2015 were analyzed in order to investigate the relationship between posttreatment SCC antigen (SCC Ag) and treatment failure in such individuals with cervical SCC treated with CCRT. The multivariate analysis explicated that an independent prognostic factor of disease-free survival was posttreatment SCC Ag. Therefore, because of a high rate of treatment failure and poor survival, individuals with posttreatment SCC Ag ≥ 1.8 ng/mL, get to suffer.